Correlation Between NYSE Composite and Psyence Biomedical
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Psyence Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Psyence Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Psyence Biomedical Ltd, you can compare the effects of market volatilities on NYSE Composite and Psyence Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Psyence Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Psyence Biomedical.
Diversification Opportunities for NYSE Composite and Psyence Biomedical
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between NYSE and Psyence is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Psyence Biomedical Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Psyence Biomedical and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Psyence Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Psyence Biomedical has no effect on the direction of NYSE Composite i.e., NYSE Composite and Psyence Biomedical go up and down completely randomly.
Pair Corralation between NYSE Composite and Psyence Biomedical
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.07 times more return on investment than Psyence Biomedical. However, NYSE Composite is 14.33 times less risky than Psyence Biomedical. It trades about 0.14 of its potential returns per unit of risk. Psyence Biomedical Ltd is currently generating about -0.18 per unit of risk. If you would invest 1,804,550 in NYSE Composite on September 3, 2024 and sell it today you would earn a total of 216,772 from holding NYSE Composite or generate 12.01% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Psyence Biomedical Ltd
Performance |
| Timeline |
NYSE Composite and Psyence Biomedical Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Psyence Biomedical Ltd
Pair trading matchups for Psyence Biomedical
Pair Trading with NYSE Composite and Psyence Biomedical
The main advantage of trading using opposite NYSE Composite and Psyence Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Psyence Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Psyence Biomedical will offset losses from the drop in Psyence Biomedical's long position.| NYSE Composite vs. Lindblad Expeditions Holdings | NYSE Composite vs. LB Foster | NYSE Composite vs. HUTCHMED DRC | NYSE Composite vs. Bridgford Foods |
| Psyence Biomedical vs. DiaMedica Therapeutics | Psyence Biomedical vs. Lyra Therapeutics | Psyence Biomedical vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |